|
|
|
|
|
My Recent Searches
|
|
|
|
|
|
|
Foamix Pharmaceuticals Ltd (FOMX) |
|
|
$3.24 0.00 (0.00%) as of 4:30 Thu 3/5
|
|
Download |
|
|
|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
36,600,000 |
Market
Cap: |
118.58(M) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$3.24 - $3.24 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2023-12-28 |
2023-09-26 |
2023-03-28 |
2022-03-28 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Stern Stanley |
Director |
|
2020-03-09 |
4 |
D |
$0.00 |
$0 |
D/D |
(42,359) |
0 |
|
- |
|
Stuart Iain |
Chief Scientific Officer |
|
2020-03-09 |
4 |
D |
$0.00 |
$0 |
D/D |
(103,636) |
0 |
|
- |
|
Wiley Matthew T. |
Chief Commercial Officer |
|
2020-03-09 |
4 |
D |
$0.00 |
$0 |
D/D |
(114,074) |
0 |
|
- |
|
Hadar Ilan |
CFO & Country Manager |
|
2020-03-09 |
4 |
D |
$0.00 |
$0 |
D/D |
(130,578) |
0 |
|
- |
|
Hirsch Stanley |
Director |
|
2020-03-09 |
4 |
D |
$0.00 |
$0 |
D/D |
(111,858) |
0 |
|
- |
|
Hirsch Stanley |
Director |
|
2020-03-09 |
4 |
D |
$0.00 |
$0 |
I/I |
(182,500) |
59,016 |
|
- |
|
Schwartz Aharon |
Director |
|
2020-03-09 |
4 |
D |
$0.00 |
$0 |
D/D |
(112,200) |
0 |
|
- |
|
Bruno Anthony D |
Director |
|
2020-03-09 |
4 |
D |
$0.00 |
$0 |
D/D |
(75,007) |
0 |
|
- |
|
Harsch Mutya |
CLO and General Counsel |
|
2020-03-09 |
4 |
D |
$0.00 |
$0 |
D/D |
(98,232) |
0 |
|
- |
|
Kazanchyan Anna |
Director |
|
2020-03-09 |
4 |
D |
$0.00 |
$0 |
D/D |
(58,744) |
0 |
|
- |
|
Domzalski David |
CEO |
|
2020-03-09 |
4 |
D |
$0.00 |
$0 |
D/D |
(324,028) |
0 |
|
- |
|
Wiley Matthew T. |
Chief Commercial Officer |
|
2020-03-02 |
4 |
A |
$2.68 |
$5,336 |
D/D |
1,993 |
114,074 |
|
- |
|
Domzalski David |
CEO |
|
2020-03-02 |
4 |
A |
$2.68 |
$12,598 |
D/D |
4,705 |
324,028 |
|
- |
|
Harsch Mutya |
CLO and General Counsel |
|
2020-03-02 |
4 |
A |
$2.68 |
$4,715 |
D/D |
1,761 |
98,232 |
|
- |
|
Kazanchyan Anna |
Director |
|
2020-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
21,246 |
58,744 |
|
- |
|
Bruno Anthony D |
Director |
|
2020-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
5,312 |
75,007 |
|
- |
|
Stern Stanley |
Director |
|
2020-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
14,164 |
42,359 |
|
- |
|
Hirsch Stanley |
Director |
|
2020-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
42,493 |
111,858 |
|
- |
|
Harsch Mutya |
CLO and General Counsel |
|
2020-02-24 |
4 |
A |
$0.00 |
$0 |
D/D |
41,299 |
96,471 |
|
- |
|
Domzalski David |
CEO |
|
2020-02-24 |
4 |
A |
$0.00 |
$0 |
D/D |
103,248 |
319,323 |
|
- |
|
Wiley Matthew T. |
Chief Commercial Officer |
|
2020-02-24 |
4 |
A |
$0.00 |
$0 |
D/D |
41,299 |
112,081 |
|
- |
|
Stuart Iain |
Chief Scientific Officer |
|
2020-02-24 |
4 |
A |
$0.00 |
$0 |
D/D |
41,299 |
103,636 |
|
- |
|
Hadar Ilan |
CFO & Country Manager |
|
2020-02-24 |
4 |
A |
$0.00 |
$0 |
D/D |
41,299 |
130,578 |
|
- |
|
Wiley Matthew T. |
Chief Commercial Officer |
|
2019-12-31 |
4 |
D |
$3.28 |
$8,200 |
D/D |
(2,500) |
70,782 |
|
- |
|
Domzalski David |
CEO |
|
2019-12-31 |
4 |
D |
$3.28 |
$9,023 |
D/D |
(2,751) |
216,075 |
|
- |
|
111 Records found
|
|
Page 1 of 5 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|